DOST exploring lagundi as a potential treatment for COVID-19
The Department of Science and Technology is exploring herbal medicine lagundi as a potential treatment for the coronavirus disease 2019 (COVID-19). In a report on “24 Oras Weekend,” DOST Secretary Fortunato dela Peña said lagundi had anti-viral and anti-inflammatory properties that could possibly help improve the treatment of patients.
“Itong lagundi, siya kasi ay mayroong approval as a drug for cough, ‘yong mga parang sa respiratory. ‘Yon ang kauna-unahang halamang gamot na naging available over the counter sa mga botika at ngayon may mga anti-viral na properties at tsaka mayroon din siyang anti-inflammatory. Tamang-tama siyang subukan para sa pag-address ng mga symptoms ng COVID-19,” dela Peña said.
However, he said that lagundi would only be tested on mild COVID-19 cases.
“Para sa mga mild cases kasi ang ia-address dito ay ‘yong symtpoms kamukha ng ubo, sakit ng lalamunan, lagnat at ang titignan diyan ay kung mawawala ang mga symptoms na ‘yon kasi siyempre magiginhawahan ang pasyente,” dela Peña said.
Aside from lagundi, the DOST was also exploring other herbal medicines such as virgin coconut oil and tawa-tawa for the treatment of COVID-19.
Dela Peña also clarified that clearance from the Food and Drug Administration was needed before commencing with clinical trials.
Meanwhile, as of yesterday, July 19, the Philippines has 67,456 total cases, with 2,241 new cases reported, a big majority coming from Metro Manila.
